Clinical Investigation in Effect of Riboflavin Sodium Phosphate on Prevention and Treatment for Patients with Radiotherapy Related Esophagitis

Abstract

Objective: To investigate the clinical effect of riboflavin sodium phosphate on prevention of radiotherapy related esophagitis (RRE). Methods: This retrospective study involved 55 patients with middle and advanced esophageal cancer who were divided into an experimental group of 28 and a control group of 27 patients. Those in the experimental group were treated with riboflavin sodium phosphate combined with conventional symptomatic treatment during radiotherapy; while patients in control group received the latter alone. The incidence and degree of RRE were compared after radiotherapy. Results: The incidences of RRE in experimental and control group were 53.5% and 81.4%, respectively (p<0.05); the incidence of stages III and IV RRE in the experimental group was 17.8%, while in the control group it was 44.4% (p<0.05). Conclusion: Riboflavin sodium phosphate could significantly prevent RRE and reduce the incidence of stage III and IV disease. These results were worthy of further confirmation by randomized controlled trials.

Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis

“…After at least two courses of treatment, safety and effectiveness were evaluated. We have enough experience in conducting medical researches, and have published some results elsewhere Cao et al, 2014;Cui et al, 2014;Ji et al, 2014;Lu et al, 2014;Qian et al, Tian et al, 2014;Xiao et al, 2014;Xiao et al, 2014;Wang et al, 2014;Wu et al, 2014;Li et al, 2015;Qian et al, 2015;Shen et al, 2015;Shi et al, 2015;Sun et al, 2015;Wang et al, 2015;Yang et al, 2015;Zhou et al, 2015)…”

A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia

“…After TP and PTP were attempted, safety and effectiveness were evaluated. We have enough experience in conducting medical researches, and have published some cancer related results elsewhere Cao et al, 2014;Cui et al, 2014;Ji et al, 2014;Lu et al, 2014;Qian et al, Tian et al, 2014;Wu et al, 2014;Cui et al, 2015;Li et al, 2015;Qian et al, 2015;Shen et al, 2015;Shi et al, 2015;Sun et al, 2015;Wang et al, 2015;Yang et al, 2015;Zhou et al, 2015) …”